Stay updated on Pembrolizumab in cSCC: Recurrent/Metastatic Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in cSCC: Recurrent/Metastatic Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in cSCC: Recurrent/Metastatic Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.4 to v3.6.5, indicating a new version of the page's documentation/template. This update records a small adjustment to the page's revision history.
    Difference
    0.0%
    Check dated 2026-08-11T20:45:15.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision: v3.6.4 replaces the previous v3.6.3 on the page, indicating a small internal update. This change does not alter trial data, eligibility, or public content beyond the revision tag.
    Difference
    0.0%
    Check dated 2026-07-21T12:44:52.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page's revision stamp changed from v3.6.0 to v3.6.3, indicating a newer version of the page content.
    Difference
    0.0%
    Check dated 2026-06-30T00:54:40.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Recruitment status updated to 'No longer looking for participants', indicating the study is not recruiting. New help and navigation items have been added ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'); the 'Intervention/Treatment' label was updated and a revision note 'Revision: v3.6.0' was added.
    Difference
    0.3%
    Check dated 2026-06-15T15:58:44.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.5.4 to v3.5.5, indicating a new iteration of the document. The change represents an update to the page’s metadata rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-06-08T15:19:48.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The Revision field was updated from v3.5.3 to v3.5.4, indicating a newer document version. This update appears to be an administrative version change rather than a modification to study content or procedures.
    Difference
    0.0%
    Check dated 2026-05-18T03:30:34.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in cSCC: Recurrent/Metastatic Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in cSCC: Recurrent/Metastatic Clinical Trial page.